Capture

WHITE PAPERS AND CASE STUDIES

• eCOA: Unified Approach Streamlines Processes, Speeds Start Up And Improves Data Quality

  Discover how a leading biopharmaceutical company revolutionized its clinical development with an eCOA solution that optimized its processes, cut build times, and enhanced data quality.

• Patient-Focused Data Capture For Cancer Research

  In a field where innovation is constant and patient experience is pivotal, oncology demands eCOA solutions designed to balance scientific rigor with human realities.

• No More Swiss Holes: Filling The Gaps In Clinical Trial Disclosure

  This use case shows how sponsors can gain clarity on disclosure requirements when entering a new country.

• Comparative Analysis Of Batch And Continuous Processes

  Explore a comparative analysis that showcases the superior performance of continuous processing over traditional batch methods, highlighting key improvements in efficiency and environmental impact.

• Continuous Cough Monitoring: Addressing Placebo Effects And Data Gaps

  Modernizing symptom monitoring is essential to improving clinical trial quality, and these tools deliver richer, more accurate data that can help close information gaps.

• Patient Selection By Anti-AAV Total Antibody Binding

  Advance the future of medicine by harnessing AAV-based gene therapies — powerful delivery systems that drive safer, more effective, and potentially curative treatments for genetic disorders.

• Optimizing Local Affiliate PV Operations

  Discover how a global biopharmaceutical company partnered with PharmaLex to implement a streamlined, standardized model for international ICSR processing, compliance, and cross-functional collaboration.

• Guide To Seeding, Expanding, And Harvesting Stem Cells

  Investigate important considerations for working with three different stem cell types: mesenchymal stem/stromal cells, induced pluripotent stem cells, and neural stem cells.

• Epigenetics Application Guide: RNA Modifications

  Learn about the rapidly evolving field of RNA modifications, including innovative techniques like miCLIP and RIP for mapping chemical modifications and understanding RNA’s role in cellular processes.

• Reducing ADC Timelines With Integrated Development And Manufacturing

  ADCs have proven to be highly effective in cancer treatment, but their manufacturing poses challenges. Learn how a CDMO partner can help bring these treatments to patients safely and efficiently.

• The 5 Ws Of A Human Factors Strategy

  A human factors strategy ensures medical products are safe, effective, and compliant by integrating user-focused design early, reducing risks, and optimizing regulatory approval processes.

• Isolate Bright GFP-Expressing HEK293 Cells For Cell Line Development Workflow

  Explore a high-efficiency workflow for isolating and expanding GFP-expressing HEK293 cells that enables stable, bright clones ideal for imaging and tracking to simplify clonal development.